Percutaneous Sclerotherapy of Venous Malformations.
ethanol
sclerotherapy
sodium tetradecyl sulfate
therapeutic embolization
vascular malformations
Journal
Techniques in vascular and interventional radiology
ISSN: 1557-9808
Titre abrégé: Tech Vasc Interv Radiol
Pays: United States
ID NLM: 9806675
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
medline:
22
8
2024
pubmed:
22
8
2024
entrez:
21
8
2024
Statut:
ppublish
Résumé
Venous malformation (VM) stands as the most prevalent form of vascular malformation, characterized by its diverse morphology. These lesions can manifest in any part of the body, affecting different tissue planes and giving rise to symptoms such as pain, swelling, or physical dysfunction. In the realm of treatment, direct puncture VM sclerotherapy holds its place as the primary approach. This technique involves the administration of a sclerosing agent into the VM channels during contrast phlebography while simultaneously managing the outflow veins through different methods. The process of VM sclerotherapy induces endothelial damage, thrombosis, and fibrosis, resulting in symptom relief through lesion shrinkage. It is crucial to exercise caution techniques and sclerosing agents during VM sclerotherapy to minimize procedural complications, enhance clinical outcomes, and ultimately improve the patient's overall quality of life.
Identifiants
pubmed: 39168545
pii: S1089-2516(24)00016-7
doi: 10.1016/j.tvir.2024.100960
pii:
doi:
Substances chimiques
Sclerosing Solutions
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100960Informations de copyright
Copyright © 2024. Published by Elsevier Inc.